Nudges for Statin Prescribing in Primary Care
Completed · Not applicable
Conditions studied: Cardiovascular Diseases
In brief
The objective of the study is to evaluate the effect of nudges to clinicians, patients, or both to initiate statin prescriptions for patients that meet national guidelines.
Key facts
- Study ID
- NCT04307472
- Run by
- University of Pennsylvania
- People needed
- 4131
- Starts
- 2020-10-19
- Expected to finish
- 2021-04-18
- Last updated by the study team
- 2021-05-21
Who can join
Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Have new or return visit with a primary care provider at one of the study practices at the University of Pennsylvania Health System
- Either have an ASCVD condition, history of familial hyperlipidemia, or meet United State Preventive Task Force Guidelines for Statin Therapy which includes age 40-75 years, at least 1 cardiovascular risk factor (e.g. dyslipidemia, diabetes, hypertension, smoking), 10-year ASVCD risk score ≥ 10%
You may not qualify if…
- Already prescribed a statin
- Allergy to statins
- Severe renal insufficiency defined as glomerular filtration rate (GFR) less than 30 mL/min or on dialysis
- Adverse reaction to statins including statin-related a) myopathy; b) Rhabdomyolysis; c) hepatitis
- Pregnant
- Currently breastfeeding
- on hospice or at the end-of-life
- On a PCSK9 Inhibitor medication
- Clinicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin medication.
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.